• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.

作者信息

Bukhari Syed, Barakat Amr F, Eisele Yvonne S, Nieves Ricardo, Jain Sandeep, Saba Samir, Follansbee William P, Brownell Amy, Soman Prem

机构信息

Division of Cardiology, Department of Medicine, University of Pittsburgh, PA.

出版信息

Circulation. 2021 Mar 30;143(13):1335-1337. doi: 10.1161/CIRCULATIONAHA.120.052136. Epub 2021 Mar 29.

DOI:10.1161/CIRCULATIONAHA.120.052136
PMID:33779268
Abstract
摘要

相似文献

1
Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.野生型转甲状腺素蛋白淀粉样心肌病中心房颤动的患病率及血栓栓塞风险
Circulation. 2021 Mar 30;143(13):1335-1337. doi: 10.1161/CIRCULATIONAHA.120.052136. Epub 2021 Mar 29.
2
Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.在一名难治性心房颤动且心脏影像学检查无异常的患者中发现早期野生型转甲状腺素蛋白淀粉样变性心肌病
Circ Heart Fail. 2018 Jul;11(7):e004812. doi: 10.1161/CIRCHEARTFAILURE.117.004812.
3
Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review.心脏淀粉样变性中的心房颤动、血栓栓塞风险及抗凝治疗：综述
J Card Fail. 2023 Jan;29(1):76-86. doi: 10.1016/j.cardfail.2022.08.008. Epub 2022 Sep 17.
4
Wild-type transthyretin cardiac amyloidosis diagnosed in a patient in his 50s.一名50多岁的患者被诊断出患有野生型转甲状腺素蛋白心脏淀粉样变性。
BMJ Case Rep. 2020 Jun 30;13(6):e236656. doi: 10.1136/bcr-2020-236656.
5
No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients With Transthyretin Amyloidosis.转甲状腺素蛋白淀粉样变性患者的CHADS-VASc评分与左心耳血栓之间无关联。
JACC Clin Electrophysiol. 2019 Dec;5(12):1473-1474. doi: 10.1016/j.jacep.2019.10.013.
6
Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.淀粉样变心肌病中心房颤动：患病率、发病率、危险因素和预后作用。
Amyloid. 2015;22(3):147-55. doi: 10.3109/13506129.2015.1028616. Epub 2015 Jun 5.
7
Response: Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.反应：转甲状腺素蛋白心脏淀粉样变性中的心房损害：心脏受累的早期标志物和预后因素。
Amyloid. 2018 Jun;25(2):136. doi: 10.1080/13506129.2018.1450241. Epub 2018 Mar 12.
8
Myocardial Mitochondrial Function Is Impaired in Cardiac Light-Chain Amyloidosis Compared to Transthyretin Amyloidosis.与转甲状腺素蛋白淀粉样变性相比，心脏轻链淀粉样变性患者的心肌线粒体功能受损。
JACC Heart Fail. 2024 Oct;12(10):1778-1780. doi: 10.1016/j.jchf.2024.03.012. Epub 2024 May 22.
9
Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.心脏淀粉样变中心房颤动和心房颤动亚型：临床和超声心动图特征及其对死亡率的影响。
Amyloid. 2019 Sep;26(3):128-138. doi: 10.1080/13506129.2019.1620724. Epub 2019 Jun 7.
10
Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.转甲状腺素蛋白心脏淀粉样变性患者传导系统疾病的患病率、发病率及其对死亡率的影响。
Am J Cardiol. 2020 Aug 1;128:140-146. doi: 10.1016/j.amjcard.2020.05.021. Epub 2020 May 16.

引用本文的文献

1
Emerging Insights into Granulomatous and Amyloidogenic Cardiomyopathies.对肉芽肿性和淀粉样变性心肌病的新见解
J Clin Med. 2025 Jun 13;14(12):4208. doi: 10.3390/jcm14124208.
2
Prevalence of Atrial Fibrillation and Intervention Therapy in Cardiac Amyloidosis.心脏淀粉样变性中房颤的患病率及干预治疗
Rev Cardiovasc Med. 2025 May 22;26(5):37064. doi: 10.31083/RCM37064. eCollection 2025 May.
3
Comparative Insights on Inpatient Outcomes in Diastolic Heart Failure with and Without Amyloidosis: A Nationwide Propensity-Matched Analysis.
伴有和不伴有淀粉样变性的舒张性心力衰竭住院结局的比较性见解：一项全国性倾向匹配分析。
J Cardiovasc Dev Dis. 2025 May 16;12(5):190. doi: 10.3390/jcdd12050190.
4
Acute Limb Ischemia Presenting as a Clinical Conundrum: Stroke Mimic or Aortic Dissection?表现为临床难题的急性肢体缺血：类似中风还是主动脉夹层？
Eur J Case Rep Intern Med. 2025 Mar 26;12(4):005317. doi: 10.12890/2025_005317. eCollection 2025.
5
Incidence and associated factors with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy: Insights from the multicenter REACT-SP registry.转甲状腺素蛋白淀粉样变心肌病患者心房颤动的发生率及相关因素：来自多中心REACT-SP注册研究的见解
Int J Cardiol Heart Vasc. 2025 Mar 25;58:101658. doi: 10.1016/j.ijcha.2025.101658. eCollection 2025 Jun.
6
Mexican position paper for the diagnosis and treatment of cardiac amyloidosis.墨西哥心脏淀粉样变性诊断和治疗立场文件
Arch Cardiol Mex. 2024;94(Supl 3):1-33. doi: 10.24875/ACM.M24000097.
7
Diagnostic Modalities in the Detection of Cardiac Amyloidosis.心脏淀粉样变性检测中的诊断方法
J Clin Med. 2024 Jul 12;13(14):4075. doi: 10.3390/jcm13144075.
8
Arrhythmic Risk Stratification in Cardiac Amyloidosis: A Review of the Current Literature.心脏淀粉样变性中的心律失常风险分层：当前文献综述
J Cardiovasc Dev Dis. 2024 Jul 14;11(7):222. doi: 10.3390/jcdd11070222.
9
Challenges associated with managing treatment complications in an older patient with cardiac amyloidosis.老年心脏淀粉样变性患者治疗并发症管理相关的挑战。
Egypt Heart J. 2024 Jun 18;76(1):75. doi: 10.1186/s43044-024-00507-0.
10
Arrhythmias and Device Therapies in Cardiac Amyloidosis.心脏淀粉样变性中的心律失常与器械治疗
J Clin Med. 2024 Feb 25;13(5):1300. doi: 10.3390/jcm13051300.